REGENXBIO Inc. ($RGNX)
Filing Information
| Accession Number | 0002023732-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 27, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
187,644
Total Value
$949,381.45
P&L
+81.8% (+$776,943.35)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 25, 2026 | Grant/Award | 15,432 | $0.00 | $0.00 | 15,432 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 26, 2026 | Purchase | 49,196 | $9.14 | $449,705.56 | 64,628 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 27, 2026 | Purchase | 53,407 | $9.36 | $499,675.89 | 118,035 | Direct | โ | View Details | |
Director | Stock Options (Right to buy) | Derivative | Aug 25, 2026 | Grant/Award | 69,609 | $0.00 | $0.00 | 69,609 | Direct | โ | View Details |